More than 10 oral and mini-oral presentations span Pfizer’s extensive Oncology portfolio of approved and investigational therapies
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
Objective response rate of 54.8% seen with Daiichi Sankyo and Merck’s ifinatamab deruxtecan at 12 mg/kg dose in pretreated patients
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
New analyses, including presentations on mavacamten, apixaban and milvexian, further solidify the company's strength and expertise as a leader in cardiovascular diseases
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
Subscribe To Our Newsletter & Stay Updated
